Showing 1 posts of 1 posts found.
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
Five Facts about NHS and primary care
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
AI in pharma: From lab development to patient impact
Back to basics: X-ray inspection in pharmaceutical and medical device production